scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJMOA044057 |
P698 | PubMed publication ID | 16135832 |
P50 | author | Nicholas John White | Q21166848 |
Kasia Stepniewska | Q30112539 | ||
Jeremy Farrar | Q15967402 | ||
P2093 | author name string | Bridget A Wills | |
M Dung Nguyen | |||
T H Tam Dong | |||
T Hao Nguyen | |||
T Loan Ha | |||
T N Thuy Tran | |||
T T Minh Le | |||
V Chau Nguyen | |||
V Diet Tran | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Dengue virus | Q476209 |
resuscitation | Q5491454 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 877-889 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Comparison of three fluid solutions for resuscitation in dengue shock syndrome | |
P478 | volume | 353 |
Q35577798 | A Prognostic Model for Development of Profound Shock among Children Presenting with Dengue Shock Syndrome |
Q35928781 | A Proteomic Approach Identifies Candidate Early Biomarkers to Predict Severe Dengue in Children |
Q27485236 | A case report of dengue virus infection and acalculous cholecystitis in a pregnant returning traveler |
Q41929302 | A predictive score for hypotension in patients with confirmed dengue fever in Cayenne Hospital, French Guiana |
Q34055609 | A retrospective analysis of the haemodynamic and metabolic effects of fluid resuscitation in Vietnamese adults with severe falciparum malaria |
Q33517961 | A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials |
Q26851753 | Advances in monitoring and management of shock |
Q44840552 | After the FEAST--fluid resuscitation in pediatric sepsis. |
Q34167384 | Assessing the prognosis of dengue-infected patients |
Q26471696 | Buffered solutions versus isotonic saline for resuscitation in non-surgical critically ill adults and children |
Q37521934 | CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients |
Q34074313 | Cardiac function in Vietnamese patients with different dengue severity grades |
Q38660225 | Cardio-haemodynamic assessment and venous lactate in severe dengue: Relationship with recurrent shock and respiratory distress |
Q40061338 | Case Management of Dengue: Lessons Learned |
Q28749460 | Choice of fluids for resuscitation in children with severe infection and shock: systematic review |
Q33389421 | Clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic area--Puerto Rico, 2007-2008 |
Q37272298 | Clinical characteristics of Dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital |
Q35954329 | Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries |
Q33402055 | Clinical features of dengue in a large Vietnamese cohort: intrinsically lower platelet counts and greater risk for bleeding in adults than children |
Q34605888 | Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. |
Q24200866 | Colloids versus crystalloids for fluid resuscitation in critically ill patients |
Q24202823 | Colloids versus crystalloids for fluid resuscitation in critically ill patients |
Q24235605 | Colloids versus crystalloids for fluid resuscitation in critically ill patients |
Q24243170 | Colloids versus crystalloids for fluid resuscitation in critically ill patients |
Q57170855 | Colloids versus crystalloids for fluid resuscitation in critically ill people |
Q40355061 | Comparison of the effects of oral hydration and intravenous fluid replacement in adult patients with non-shock dengue hemorrhagic fever in Taiwan |
Q38345631 | Controversies in the use of hydroxyethyl starch solutions in small animal emergency and critical care |
Q38392108 | Correction of hypovolemia with crystalloid fluids: Individualizing infusion therapy. |
Q33415746 | Corticosteroids in the treatment of dengue shock syndrome |
Q37084663 | Criteria of "persistent vomiting" in the WHO 2009 warning signs for dengue case classification |
Q38992396 | Current management of severe dengue infection |
Q53678344 | Dengue |
Q91271250 | Dengue |
Q29619772 | Dengue |
Q35062190 | Dengue Haemorrhagic Fever presenting as Acute Abdomen |
Q90236104 | Dengue and Chikungunya Infections in Children : Guest Editor: Bhim S. Pandhi |
Q42963067 | Dengue fever in China: an emerging problem demands attention |
Q40452000 | Dengue fever in travellers: A challenge for European physicians. |
Q35599078 | Dengue haemorrhagic fever or dengue shock syndrome in children |
Q40389581 | Dengue haemorrhagic fever or dengue shock syndrome in children. |
Q39590469 | Dengue human infection models supporting drug development |
Q92397008 | Dengue infection and advances in dengue vaccines for children |
Q40322885 | Dengue shock |
Q28542607 | Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions |
Q27026302 | Dengue viruses - an overview |
Q36306798 | Dengue-associated acute kidney injury |
Q34125057 | Dengue. |
Q27010609 | Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment |
Q47103344 | Dengue: The break-bone fever outbreak in Kerala, India |
Q28085044 | Dengue: an update on treatment options |
Q42995650 | Dengue: translating scientific progress into workable solutions |
Q34009077 | Dextran fractional clearance studies in acute dengue infection |
Q28357303 | Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study |
Q39494603 | Disease control priorities for neglected tropical diseases: lessons from priority ranking based on the quality of evidence, cost effectiveness, severity of disease, catastrophic health expenditures, and loss of productivity |
Q36022394 | Dynamic Measurement of Hemodynamic Parameters and Cardiac Preload in Adults with Dengue: A Prospective Observational Study |
Q83393609 | Early fluid resuscitation |
Q34233736 | Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety |
Q38690643 | Effect of dextran-70 on outcome in severe sepsis; a propensity-score matching study. |
Q33402687 | Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial |
Q91909029 | El dengue |
Q34621758 | Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial |
Q58556570 | Fluid Bolus Therapy in Pediatric Sepsis: Current Knowledge and Future Direction |
Q27006918 | Fluid management for dengue in children |
Q58484733 | Fluid resuscitation for children with severe febrile illness and septic shock in resource-limited settings |
Q24203806 | Fluid resuscitation for children with severe febrile illness and septic shock in resource-limited settings |
Q79769004 | Fluid resuscitation in neonatal and pediatric hypovolemic shock: a Dutch Pediatric Society evidence-based clinical practice guideline |
Q79768991 | Fluid resuscitation of hypovolemic shock: acute medicine's great triumph for children |
Q39395879 | Global advocacy needed for sepsis in children |
Q36558930 | Global distribution of infectious diseases requiring intensive care |
Q38075296 | Global paediatric advanced life support: improving child survival in limited-resource settings |
Q50041310 | Haemodynamic assessment and support in sepsis and septic shock in resource-limited settings |
Q22306541 | Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis |
Q40334688 | Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys. |
Q45335455 | Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis |
Q58037992 | Kurzdarstellung |
Q90402929 | Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock |
Q34160073 | Liver involvement associated with dengue infection in adults in Vietnam |
Q29571044 | Management and outcomes of severe dengue patients presenting with sepsis in a tropical country |
Q27002625 | Mortality after fluid bolus in children with shock due to sepsis or severe infection: a systematic review and meta-analysis |
Q21999119 | Mosquito-borne Diseases |
Q28296618 | Neurological complications of dengue virus infection |
Q28081774 | Overcoming tumor immune evasion with an unique arbovirus |
Q30543305 | Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations |
Q22306357 | Part 12: Pediatric Advanced Life Support |
Q58997716 | Pathogenesis of Dengue Haemorrhagic Fever and Its Impact on Case Management |
Q31146025 | Pathogenic flaviviruses. |
Q37770419 | Pediatric Sepsis Guidelines: Summary for resource-limited countries |
Q37200292 | Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations |
Q37562992 | Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents |
Q39574189 | Pediatric sepsis: preparing for the future against a global scourge. |
Q42547755 | Phase III trials required to resolve clinical equipoise over optimal fluid management in children with severe malaria |
Q50255448 | Plasma leakage in dengue haemorrhagic fever |
Q21146686 | Predicting outcome from dengue |
Q47361874 | Prevention and Therapy of Acute Kidney Injury in the Developing World |
Q28729782 | Prevention and control of dengue-the light at the end of the tunnel |
Q38605203 | Recent advances in dengue pathogenesis and clinical management |
Q37260357 | Recent advances in sepsis and septic shock |
Q30511819 | Recommendations for sepsis management in resource-limited settings |
Q38975850 | Recommendations for the management of severe malaria and severe dengue in resource-limited settings |
Q35053872 | Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study |
Q26991990 | Safety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediatric patients: a meta-analysis of randomized controlled trials |
Q37256595 | Sepsis and septic shock: progress and future considerations |
Q94452532 | Severe Dengue: Lessons learnt from an observational study |
Q33831014 | Should colloid boluses be prioritized over crystalloid boluses for the management of dengue shock syndrome in the presence of ascites and pleural effusions? |
Q34431514 | Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults |
Q29615429 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 |
Q24644984 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 |
Q91901511 | The Assessment, Evaluation, and Management of the Critically Ill Child When Resources are Limited-Southeast Asian Perspective |
Q28551039 | The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria |
Q36531302 | The WHO dengue classification and case definitions: time for a reassessment |
Q30619692 | The fluid management of adults with severe malaria |
Q37904027 | The pathogenesis of dengue |
Q38443785 | The reliability of the physical examination to guide fluid therapy in adults with severe falciparum malaria: an observational study |
Q38032553 | Treatment of dengue fever |
Q30145525 | Trends of Dengue Disease Epidemiology |
Q33919446 | Update on pediatric sepsis: a review. |
Q34563675 | Utilities and limitations of the World Health Organization 2009 warning signs for adult dengue severity |
Q35494604 | Validation of probability equation and decision tree in predicting subsequent dengue hemorrhagic fever in adult dengue inpatients in Singapore |
Q50162593 | Volume replacement in intensive care medicine |
Search more.